Published in J Clin Psychiatry on January 01, 1995
Meta-analysis of naltrexone and acamprosate for treating alcohol use disorders: when are these medications most helpful? Addiction (2012) 2.64
Naltrexone effects on alcohol consumption in a clinical laboratory paradigm: temporal effects of drinking. Psychopharmacology (Berl) (2004) 1.66
GDNF is a fast-acting potent inhibitor of alcohol consumption and relapse. Proc Natl Acad Sci U S A (2008) 1.35
Maintenance medication for opiate addiction: the foundation of recovery. J Addict Dis (2012) 1.25
Sweet liking phenotype, alcohol craving and response to naltrexone treatment in alcohol dependence. Alcohol Alcohol (2009) 0.97
Age at onset typology in opioid dependent men: an exploratory study. Indian J Psychiatry (2002) 0.89
Pharmacological approaches to reducing craving in patients with alcohol use disorders. CNS Drugs (2014) 0.86
Placebo group improvement in trials of pharmacotherapies for alcohol use disorders: a multivariate meta-analysis examining change over time. J Clin Psychopharmacol (2013) 0.84
Extended naltrexone and broad spectrum treatment or motivational enhancement therapy. Psychopharmacology (Berl) (2009) 0.80
Naltrexone's suppressant effects on drinking are limited to the first 3 months of treatment. Psychopharmacology (Berl) (2007) 0.77
Advances in alcoholic liver disease: An update on alcoholic hepatitis. World J Gastroenterol (2015) 0.75
Difference of the naltrexone's effects in social drinkers by spicy food preference. J Korean Med Sci (2014) 0.75
Dihydrocodeine/Agonists for alcohol dependents. Front Psychiatry (2012) 0.75
Pharmacoprophylaxis of alcohol dependence: Review and update Part II: Efficacy. Indian J Psychiatry (2007) 0.75
Emerging concepts in alcoholic hepatitis. World J Hepatol (2017) 0.75
An improved diagnostic evaluation instrument for substance abuse patients. The Addiction Severity Index. J Nerv Ment Dis (1980) 14.25
Drug dependence, a chronic medical illness: implications for treatment, insurance, and outcomes evaluation. JAMA (2000) 14.17
New data from the Addiction Severity Index. Reliability and validity in three centers. J Nerv Ment Dis (1985) 9.12
Limbic activation during cue-induced cocaine craving. Am J Psychiatry (1999) 6.66
The effects of psychosocial services in substance abuse treatment. JAMA (1993) 5.87
Naltrexone in the treatment of alcohol dependence. Arch Gen Psychiatry (1992) 5.48
Human immunodeficiency virus seroconversion among intravenous drug users in- and out-of-treatment: an 18-month prospective follow-up. J Acquir Immune Defic Syndr (1993) 5.08
A new measure of substance abuse treatment. Initial studies of the treatment services review. J Nerv Ment Dis (1992) 4.64
Similarity of outcome predictors across opiate, cocaine, and alcohol treatments: role of treatment services. J Consult Clin Psychol (1994) 2.31
Conditioned responses to cocaine-related stimuli in cocaine abuse patients. Psychopharmacology (Berl) (1992) 2.29
Brain activity during simulated deception: an event-related functional magnetic resonance study. Neuroimage (2002) 2.26
Predicting response to alcohol and drug abuse treatments. Role of psychiatric severity. Arch Gen Psychiatry (1983) 2.25
Cue reactivity and cue reactivity interventions in drug dependence. NIDA Res Monogr (1993) 2.23
Partial characterization of lipids that develop during the routine storage of blood and prime the neutrophil NADPH oxidase. J Lab Clin Med (1994) 2.13
Comparative effectiveness and costs of inpatient and outpatient detoxification of patients with mild-to-moderate alcohol withdrawal syndrome. N Engl J Med (1989) 2.11
Naltrexone and alcohol dependence. Role of subject compliance. Arch Gen Psychiatry (1997) 2.07
Therapist success and its determinants. Arch Gen Psychiatry (1985) 2.00
Naltrexone pharmacotherapy for opioid dependent federal probationers. J Subst Abuse Treat (1998) 1.98
Problem-service 'matching' in addiction treatment. A prospective study in 4 programs. Arch Gen Psychiatry (1997) 1.96
Attenuation of the euphoric effects of cocaine by the dopamine D1/D5 antagonist ecopipam (SCH 39166) Arch Gen Psychiatry (1999) 1.94
Evaluating the effectiveness of addiction treatments: reasonable expectations, appropriate comparisons. Milbank Q (1996) 1.78
Abstinent opiate abusers exhibit conditioned craving, conditioned withdrawal and reductions in both through extinction. Br J Addict (1986) 1.69
Cocaine dependence: a disease of the brain's reward centers. J Subst Abuse Treat (2001) 1.68
Effect of smoking cues and cigarette availability on craving and smoking behavior. Addict Behav (1996) 1.66
Comparing levels of cocaine cue reactivity in male and female outpatients. Drug Alcohol Depend (1999) 1.64
Improving naltrexone response: an intervention for medical practitioners to enhance medication compliance in alcohol dependent patients. J Addict Dis (2000) 1.62
Using cue reactivity to screen medications for cocaine abuse: a test of amantadine hydrochloride. Addict Behav (1992) 1.57
Three decision-making tasks in cocaine-dependent patients: do they measure the same construct? Addiction (2001) 1.56
Classically conditioned responses in opioid and cocaine dependence: a role in relapse? NIDA Res Monogr (1988) 1.56
Increase in desipramine serum levels associated with methadone treatment. Am J Psychiatry (1989) 1.53
Effect of random versus nonrandom assignment in a comparison of inpatient and day hospital rehabilitation for male alcoholics. J Consult Clin Psychol (1995) 1.52
Effect of naltrexone on subjective alcohol response in subjects at high and low risk for future alcohol dependence. Psychopharmacology (Berl) (1997) 1.49
Effect of naltrexone on alcohol "high" in alcoholics. Am J Psychiatry (1995) 1.49
Use of disulfiram for alcoholics in methadone maintenance programs. A Veterans Administration Cooperative Study. Arch Gen Psychiatry (1983) 1.47
Predicting treatment response to naltrexone: the influence of craving and family history. Am J Addict (2001) 1.46
Psychotherapy for opiate addicts. Does it help? Arch Gen Psychiatry (1983) 1.42
Progress in the science of addiction. Am J Psychiatry (1997) 1.41
Cocaine withdrawal symptoms and initial urine toxicology results predict treatment attrition in outpatient cocaine dependence treatment. Psychol Addict Behav (2001) 1.41
Increased effectiveness of substance abuse treatment. A prospective study of patient-treatment "matching". J Nerv Ment Dis (1983) 1.40
Crack cocaine abuse: an epidemic with many public health consequences. Annu Rev Public Health (1996) 1.34
The priming of neutrophils by lipopolysaccharide for production of intracellular platelet-activating factor. Potential role in mediation of enhanced superoxide secretion. J Immunol (1988) 1.33
Sociopathy and psychotherapy outcome. Arch Gen Psychiatry (1985) 1.31
Conditioned responses in a methadone population. A comparison of laboratory, clinic, and natural settings. J Subst Abuse Treat (1986) 1.28
Private substance abuse treatments: are some programs more effective than others? J Subst Abuse Treat (1993) 1.25
Can induced moods trigger drug-related responses in opiate abuse patients? J Subst Abuse Treat (1994) 1.24
Effectiveness and costs of inpatient versus day hospital cocaine rehabilitation. J Nerv Ment Dis (1994) 1.23
Psychotherapy in community methadone programs: a validation study. Am J Psychiatry (1995) 1.23
Predictors of participation in aftercare sessions and self-help groups following completion of intensive outpatient treatment for substance abuse. J Stud Alcohol (1998) 1.19
Analysis of the priming activity of lipids generated during routine storage of platelet concentrates. Transfusion (1996) 1.19
A comparison of the effects of the opioid antagonists naltrexone, naltrindole, and beta-funaltrexamine on ethanol consumption in the rat. Alcohol (1998) 1.17
Conditioned narcotic withdrawal in humans. Science (1977) 1.16
Phosphatidylethanolamine has an essential role in Saccharomyces cerevisiae that is independent of its ability to form hexagonal phase structures. J Biol Chem (2001) 1.13
Development of psychiatric illness in drug abusers. Possible role of drug preference. N Engl J Med (1979) 1.13
Continuing care for cocaine dependence: comprehensive 2-year outcomes. J Consult Clin Psychol (1999) 1.11
Is treatment for substance abuse effective? JAMA (1982) 1.10
Relationship of perceived competencies, perceived social support, and gender to substance use in young adolescents. J Am Acad Child Adolesc Psychiatry (1997) 1.10
Group counseling versus individualized relapse prevention aftercare following intensive outpatient treatment for cocaine dependence: initial results. J Consult Clin Psychol (1997) 1.09
Risk factors for needle sharing among methadone-treated patients. Am J Psychiatry (1991) 1.06
Naltrexone biotransformation and incidence of subjective side effects: a preliminary study. Alcohol Clin Exp Res (1997) 1.04
Synthesis and back exchange of 18O labeled amino acids for use as internal standards with mass spectrometry. Biomed Mass Spectrom (1979) 1.03
Preparation of labeled molecules by exchange with oxygen-18 water. Methods Enzymol (1990) 1.02
Relationships among physiological and self-report responses produced by cocaine-related cues. Addict Behav (1997) 1.02
Autocrine/paracrine involvement of platelet-activating factor and transforming growth factor-beta in the induction of phosphatidylserine recognition by murine macrophages. J Immunol (1995) 1.01
Acute keratinocyte damage stimulates platelet-activating factor production. Arch Dermatol Res (2000) 1.01
Effect of acamprosate and naltrexone, alone or in combination, on ethanol consumption. Alcohol (2001) 1.00
Prognostic significance of antisocial personality disorder in cocaine-dependent patients entering continuing care. J Nerv Ment Dis (2000) 0.99
Effects of contingent payment on compliance with a naltrexone regimen. Am J Drug Alcohol Abuse (1979) 0.99
Gender differences in comorbidly depressed alcohol-dependent outpatients. Alcohol Clin Exp Res (1997) 0.97
Carbamazepine treatment for cocaine dependence. Drug Alcohol Depend (1995) 0.97
Effects of an appointment reminder call on patient show rates. J Subst Abuse Treat (1995) 0.97
On the metabolic acidosis of ethylene glycol intoxication. Toxicol Appl Pharmacol (1977) 0.97
The effects of naltrexone on alcohol and cocaine use in dually addicted patients. J Subst Abuse Treat (1999) 0.96
Alcohol and drug abuse treatment in three different populations: is there improvement and is it predictable? Am J Drug Alcohol Abuse (1986) 0.96
Misuse and abuse of diazepam: an increasingly common medical problem. Int J Addict (1975) 0.96
Experimental analysis of conditioning factors in human narcotic addiction. Pharmacol Rev (1975) 0.95
Twelve-month follow-up of psychotherapy for opiate dependence. Am J Psychiatry (1987) 0.94
Severity of psychiatric symptoms as a predictor of benefits from psychotherapy: the Veterans Administration-Penn study. Am J Psychiatry (1984) 0.94
Myxoid tumor of the uterus and right atrial myxomas. S D J Med (1983) 0.93
Pneumatosis cystoides intestinalis--bullous emphysema of the intestine. A review of the literature. Am J Gastroenterol (1971) 0.93
Psychosocially enhanced treatment for cocaine-dependent mothers: evidence of efficacy. J Subst Abuse Treat (2000) 0.93
Mood state and recent cocaine use are not associated with levels of cocaine cue reactivity. Drug Alcohol Depend (2000) 0.92
Damage to the superior gluteal nerve after two different approaches to the hip. J Bone Joint Surg Br (1999) 0.92
Random versus nonrandom assignment in the evaluation of treatment for cocaine abusers. J Consult Clin Psychol (1998) 0.92
Extinguishing conditioned responses during opiate dependence treatment turning laboratory findings into clinical procedures. J Subst Abuse Treat (1986) 0.92
Medical management of alcohol dependence: clinical use and limitations of naltrexone treatment. Alcohol Alcohol (1995) 0.92
Effects of naltrexone administered repeatedly across 30 or 60 days on ethanol consumption using a limited access procedure in the rat. Alcohol Clin Exp Res (1998) 0.91
Predictors of favorable outcome following naltrexone treatment. Drug Alcohol Depend (1983) 0.91
Desipramine treatment of cocaine dependence in methadone-maintained patients. Arch Gen Psychiatry (1992) 0.91
Platelet-activating factor biosynthesis induced by various stimuli in human HaCaT keratinocytes. J Invest Dermatol (1996) 0.90
Role of conditioning factors in the development of drug dependence. Psychiatr Clin North Am (1986) 0.90
Structure elucidation of platelet activating factor derived from human neutrophils. Biochem Biophys Res Commun (1984) 0.90
Experimental methanol toxicity in the primate: analysis of metabolic acidosis. Toxicol Appl Pharmacol (1975) 0.89
Predicting the outcome of psychotherapy. findings of the Penn Psychotherapy Project. Arch Gen Psychiatry (1980) 0.89
Can independent judges recognize different psychotherapies? An experience with manual-guided therapies. J Consult Clin Psychol (1982) 0.89
Social reinforcement of operant behavior in rats: a methodological note. J Exp Anal Behav (1994) 0.89
Clinical experience with naltrexone. Am J Drug Alcohol Abuse (1975) 0.88
Are the "addiction-related" problems of substance abusers really related? J Nerv Ment Dis (1981) 0.88
Copper-catalyzed oxidation mediates PAF formation in human LDL subspecies. Protective role of PAF:acetylhydrolase in dense LDL. Arterioscler Thromb Vasc Biol (1997) 0.88
Case-control association analysis of polymorphisms in the δ-opioid receptor, OPRD1, with cocaine and opioid addicted populations. Drug Alcohol Depend (2012) 0.88